These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2165713)

  • 21. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Active vaccination against early summer meningoencephalitis].
    Müller A
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1110-6. PubMed ID: 9691346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21].
    Il'enko VI; Platonov VG; Prozorova IN; Smorodintsev AA
    Tr Inst Im Pastera; 1989; 65():126-32. PubMed ID: 2560847
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of early summer meningoencephalitis. When should you vaccinate?. Interview by Dr. Beate Schumacher].
    Fiedler M
    MMW Fortschr Med; 2000 Jun; 142(23):14. PubMed ID: 10900946
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experience with killed vaccine against tick-borne encephalitis].
    Markvart K; Ostrovská A; Vlasimska H; Duniewicz M; Kulková H; Heinz F
    Cesk Epidemiol Mikrobiol Imunol; 1982 Nov; 31(6):321-8. PubMed ID: 6216960
    [No Abstract]   [Full Text] [Related]  

  • 29. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Update tick-borne encephalitis].
    Kaiser R
    MMW Fortschr Med; 2009 Mar; 151(11):38-9. PubMed ID: 19469203
    [No Abstract]   [Full Text] [Related]  

  • 31. Tick prevention in a population living in a highly endemic area.
    Stjernberg L; Berglund J
    Scand J Public Health; 2005; 33(6):432-8. PubMed ID: 16332608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study and prevention of natural-foci diseases in USSR].
    Kucheruk VV; Olsuf'ev NG; Grokhovskaia IM; Karukin BE; Tarasevich IV; Chernukha IuG
    Med Parazitol (Mosk); 1977; 46(5):537-45. PubMed ID: 580105
    [No Abstract]   [Full Text] [Related]  

  • 34. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibility of simultaneous vaccination against tularemia and tick-borne encephalitis].
    Savel'eva RA; Pchelkina AA; Ananova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jun; 49(6):86-9. PubMed ID: 5071627
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combined immunization against tuberculosis and other infections].
    Aksenenko GR
    Probl Tuberk; 1970; 48(12):8-12. PubMed ID: 5516192
    [No Abstract]   [Full Text] [Related]  

  • 37. [New gelatine-free TBE vaccines with improved safety profile].
    Nagel G; Hennig R; Bröker M
    Klin Padiatr; 2006; 218(6):379; discussion 379. PubMed ID: 17080341
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of the tularemia prevention measures in the natural foci of the Carpathian region].
    Vetchinin VV; Sukhopiatkina AA; Bat OS; Potapova VG
    Vrach Delo; 1980 Jan; (1):107-9. PubMed ID: 7376572
    [No Abstract]   [Full Text] [Related]  

  • 39. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
    Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.